Your browser doesn't support javascript.
loading
Baseline anti-citrullinated peptide antibody (ACPA) titers and serum interleukin-6 (IL-6) levels possibly predict progression of bone destruction in early stages of rheumatoid arthritis (ERA).
Saeki, Yukihiko; Kudo-Tanaka, Eriko; Ohshima, Shiro; Matsushita, Masato; Tsuji, So-ichiro; Maeda, Yu-ichi; Yoshimura, Maiko; Watanabe, Akane; Katada, Yoshinori; Harada, Yoshinori; Ichikawa, Kenji; Suenaga, Yasuo; Ohta, Yusuke; Tohma, Shigeto.
Affiliation
  • Saeki Y; Department of Clinical Research, National Hospital Organization Osaka Minami Medical Center, 2-1 Kidohigashi-machi, Kawachinagano City, Osaka 586-8521, Japan. saekiy@ommc-hp.jp
Rheumatol Int ; 33(2): 451-6, 2013 Feb.
Article in En | MEDLINE | ID: mdl-22457007
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Peptides, Cyclic / Arthritis, Rheumatoid / Autoantibodies / Interleukin-6 Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Rheumatol Int Year: 2013 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Peptides, Cyclic / Arthritis, Rheumatoid / Autoantibodies / Interleukin-6 Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Rheumatol Int Year: 2013 Type: Article Affiliation country: Japan